Source: http://www.google.com/patents/US20050176136?dq=5359317
Timestamp: 2016-07-27 02:10:44
Document Index: 61083414

Matched Legal Cases: ['Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 10', 'Application No. 09', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10', 'Application No. 10']

Patent US20050176136 - Afinity domain for analyte sensor - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAbstract of the Disclosure The preferred embodiments provide a membrane system, particularly for use on an electrochemical sensor, wherein the membrane system includes an affinity domain that dampens the effects of target interferant(s) on the sensor. The affinity domain can be layer, surface, region,...http://www.google.com/patents/US20050176136?utm_source=gb-gplus-sharePatent US20050176136 - Afinity domain for analyte sensorAdvanced Patent SearchPublication numberUS20050176136 A1Publication typeApplicationApplication numberUS 10/991,353Publication dateAug 11, 2005Filing dateNov 16, 2004Priority dateNov 19, 2003Also published asEP1711789A2, EP1711789A4, WO2005052543A2, WO2005052543A3Publication number10991353, 991353, US 2005/0176136 A1, US 2005/176136 A1, US 20050176136 A1, US 20050176136A1, US 2005176136 A1, US 2005176136A1, US-A1-20050176136, US-A1-2005176136, US2005/0176136A1, US2005/176136A1, US20050176136 A1, US20050176136A1, US2005176136 A1, US2005176136A1InventorsJohn Burd, Mark Tapsak, Rathbun RhodesOriginal AssigneeDexcom, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (99), Referenced by (431), Classifications (12), Legal Events (1) External Links: USPTO, USPTO Assignment, EspacenetAfinity domain for analyte sensor
US 20050176136 A1Abstract
[0001] This application claims the benefit of priority under 35 U.S.C. � 119(e) to U.S. Provisional Application No. 60/523,832 filed November 19, 2003, U.S. Provisional Application No. 60/587,787, filed July 13, 2004, and U.S. Provisional Application No. 60/614,683, filed September 30, 2004. Each above-referenced prior application is incorporated by reference herein in its entirety.
[0002] The present invention relates generally to systems and methods involving the detection or measurement of analytes. More particularly, the present invention relates to reducing the effects of interfering species on a signal obtained from a glucose sensor.
[0003] A variety of sensors are known that use an electrochemical cell to provide output signals by which the presence or absence of an analyte in a sample can be determined. For example in an electrochemical cell, an analyte (or a species derived from it) that is electroactive generates a detectable signal at an electrode, and this signal can be used to detect or measure the presence and/or amount within a biological sample. In some conventional sensors, an enzyme is provided that reacts with the analyte to be measured, and the byproduct of the reaction is quantified at the electrode. An enzyme has the advantage that it can be very specific to an analyte and also, when the analyte itself is not sufficiently electroactive, can be used to interact with the analyte to generate another species which is electroactive and to which the sensor can produce a desired output. In one conventional amperometric glucose oxidase-based glucose sensor, immobilized glucose oxidase catalyses the oxidation of glucose to form hydrogen peroxide, which is then quantified by amperometric measurement (e.g., increase in electrical current) at a polarized electrode.
[0004] One problem with such sensors is that they may detect other electroactive species that are not intentionally being measured (e.g., interfering species.) This causes an increase in signal strength due to the interfering species. In other words, interfering species can be compounds with an oxidation potential that overlaps with the analyte to be measured (or by product of the enzymatic reaction with the analyte). For example, in a conventional amperometric glucose oxidase-based glucose sensor, interfering species such as acetaminophen, ascorbate, and urea, are known to produce inaccurate signal strength when they are not properly controlled. Similar problems have been seen in other sensor types, for example optical techniques.
[0005] Some glucose sensors utilize a membrane system that blocks at least some selected interfering species, such as ascorbate and urea. In some such examples, at least one layer of the membrane system includes a porous structure that has a relatively impermeable matrix with a plurality of "micro holes" or pores of molecular dimensions, such that transfer through these materials is primarily due to passage of species through the pores (e.g., the layer acts as a microporous barrier or sieve block interfering species of a particular size). In other such examples, at least one layer of a membrane system defines a permeability that allows selective dissolution and diffusion of species as a solute through the layer. Unfortunately, it is difficult to find membranes that are satisfactory or reliable in use, especially in vivo, which effectively block all interfering species.
[0006] Because of the limitations found in the prior art, there is a need for an improvement that is able to reduce the effects of all interfering species, even species that are deemed difficult to eliminate, on a sensor signal.
[0007] Accordingly, in a first embodiment, a membrane suitable for use with an analyte sensor is provided, the membrane comprising an affinity domain, wherein the affinity domain comprises a sorbent having an affinity for an interfering species.
[0008] In an aspect of the first embodiment, the sorbent has an affinity for a phenol-containing species.
[0009] In an aspect of the first embodiment, the sorbent has an affinity for acetaminophen.
[0010] In an aspect of the first embodiment, the sorbent comprises an adsorbent substance.
[0011] In an aspect of the first embodiment, the adsorbent substance comprises a chromatography-packing material.
[0012] In an aspect of the first embodiment, the sorbent comprises a molecularly imprinted surface adapted to bind with the interfering species by covalent adherence.
[0013] In an aspect of the first embodiment, the sorbent comprises a molecular structure that has a geometric structure and hydrogen binding capability, wherein the molecular structure is adapted to bind with the interfering species.
[0014] In a second embodiment, an electrochemical sensor comprising the membrane of the first embodiment is provided.
[0015] In a third embodiment, a wholly implantable glucose sensor comprising the membrane of the first embodiment is provided.
[0016] In a fourth embodiment, a transcutaneous glucose sensor comprising the membrane of the first embodiment is provided.
[0017] In a fifth embodiment, an analyte sensor for measuring the concentration of an analyte in a host is provided, the sensor comprising a sensing region for sensing the analyte; and a membrane system comprising an affinity domain, the affinity domain having an affinity for an interfering species, wherein the membrane system is disposed adjacent to the sensing region.
[0018] In an aspect of the fifth embodiment, the sensing region comprises an electroactive surface and wherein the membrane system comprises an enzyme capable of reacting with the analyte.
[0019] In an aspect of the fifth embodiment, the affinity domain comprises a sorbent, wherein the sorbent is configured to slow the diffusion of the interfering species through the membrane system to the sensing region.
[0020] In an aspect of the fifth embodiment, the sorbent has an affinity for a phenol-containing species.
[0021] In an aspect of the fifth embodiment, the sorbent has an affinity for acetaminophen.
[0022] In an aspect of the fifth embodiment, the sensor is adapted for implantation in a soft tissue of the host.
[0023] In an aspect of the fifth embodiment, the sensor is adapted for whole implantation within the host.
[0024] In an aspect of the fifth embodiment, the sensor is adapted for transcutaneous implantation in the host.
[0025] Fig. 1A is a perspective view of an implantable glucose sensor 10a in one exemplary embodiment, showing a body, an electrode system, and a membrane system incorporated thereon.
[0026] Fig. 1B is a perspective view of an in vivo portion of a transcutaneous glucose sensor in one exemplary embodiment.
[0027] Fig. 1C is an illustration that represents a method of forming the sensing membrane in one embodiment.
[0028] Fig. 1D is a schematic side view of the sensing membrane in one embodiment.
[0029] Fig. 2 is a graph of interferant concentration (relative) versus time (relative), which illustrates the rise and fall of a transient interferant concentration exposed to a sensor in a host’s body.
[0030] Fig. 3 is a graph of glucose and acetaminophen concentration versus time, which shows the results from increasing addition of acetaminophen in two test membranes having affinity domains of the preferred embodiments and two control membranes without affinity domains of the preferred embodiments.
[0032] In order to facilitate an understanding of the preferred embodiment, a number of terms are defined below.
[0033] The term "interferant" and "interfering species," as used herein, are broad terms and are used in their ordinary sense, including, without limitation, species that interfere with the measurement of an analyte of interest in a sensor to produce a signal that does not accurately represent the analyte measurement. In one example of an electrochemical sensor, interfering species are compounds with oxidation potentials that overlap with the analyte to be measured.
[0034] The term "domain" as used herein is a broad term and is used in its ordinary sense, including, without limitation, regions of the biocompatible membrane that can include layers, uniform or non-uniform gradients (for example, anisotropic), functional aspects of a material, or provided as portions of the membrane.
[0035] The term "host" as used herein is a broad term and is used in its ordinary sense, including, without limitation, mammals, particularly humans.
[0036] The phrase "continuous (or continual) analyte sensing" as used herein is a broad term and is used in its ordinary sense, including, without limitation, the monitoring of an analyte concentration continuously, continually, and or intermittently (regularly or irregularly), for example, from about less than a second to about every 10 minutes or more.
[0037] The term "sensing region" as used herein is a broad term and is used in its ordinary sense, including, without limitation, the region of a monitoring device responsible for the detection of a particular analyte. In one embodiment, the sensing region generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connective means at another location on the body, and a membrane system affixed to the body and covering the electrochemically reactive surface. During general operation of the sensor a biological sample (for example, blood or interstitial fluid) or a portion thereof contacts (directly or after passage through one or more membranes or domains) an enzyme (for example, glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte (for example, glucose) level in the biological sample. In some embodiments, the membrane system further comprises an enzyme domain (for example, an enzyme layer), and an electrolyte phase (namely, a free-flowing liquid phase comprising an electrolyte-containing fluid described further below). However, the term is sufficiently broad so as to encompass a variety of sensing techniques, for example, enzymatic, chemical, physical, optical, electrochemical, spectrophotometric, polarimetric, amperometric, calorimetric, radiometric, and the like.
[0038] The terms "electrochemically reactive surface" and "electroactive surface" as used herein are broad terms and are used in their ordinary sense, including, without limitation, the surface of an electrode where an electrochemical reaction takes place. In the case of the working electrode, the hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating a measurable electronic current (for example, detection of glucose analyte utilizing glucose oxidase produces H2O2 peroxide as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2e-) and one molecule of oxygen (O2) which produces the electronic current being detected). In the case of the counter electrode, a reducible species, for example, O2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
[0039] The term "high oxygen solubility domain" as used herein is a broad term and is used in its ordinary sense, including, without limitation, a domain composed of a material that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. The domain can then act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains. Thus, this ability of the high oxygen solubility domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
The terms "membrane system" and "membrane" as used herein, are broad terms and are used in their ordinary sense, including, but not limited to, a membrane comprising one or more domains, layers, regions, or portions.
The term "sorbent" as used herein, is a broad term and is used in its ordinary sense, including, without limitation, to take up and hold by either adsorption or absorption.
[0040] The term "sorb," as used herein, is a broad term and is used in its ordinary sense, including, without limitation, to take up and hold by either adsorption or absorption.
[0041] The terms "adsorbent" and "adsorbant" as used herein are broad terms and are used in their ordinary sense, including, without limitation, a substance that collects molecules of another substance on its surface.
[0042] The terms "absorbent" and "absorbant" as used herein, are broad terms and are used in their ordinary sense, including, without limitation, a substance that takes in and makes a part of an existent whole.
[0043] The term "sol-gel material," as used herein, is a broad term and is used in its ordinary sense, including, without limitation, a material that is prepared using a sol-gel method, for example, preparing specialty metal oxide glasses and ceramics by hydrolyzing a chemical precursor or mixture of chemical precursors that pass sequentially through a solution state and a gel state before being dehydrated to a glass or ceramic. Typically, the chemical precursors are metal alkoxides such as tetraethylorthosilicate.
[0044] The preferred embodiments relate to the use of an analyte-measuring device that measures a concentration of analyte or a substance indicative of the concentration or presence of the analyte. In some embodiments, the analyte-measuring devices measure glucose. In alternative some embodiments, the analyte-measuring devices measure other analytes, for example, oxygen, lactate, cholesterol, amino acids, or the like, as is appreciated by one skilled in the art. In some embodiments, the analyte-measuring device is a continuous device, for example a subcutaneous, transdermal, or intravascular device. In some embodiments, the device can analyze a plurality of intermittent blood samples. In some embodiments, the device can analyze a single blood sample.
[0045] Although the preferred embodiments illustrate and describe two examples of electrochemical analyte-measuring devices, the affinity domain of the preferred embodiments can be implemented with a wide variety of known analyte-measuring devices, including chemical, physical, optical, electrochemical, spectrophotometric, polarimetric, amperometric, calorimetric, radiometric, or the like. Some analyte-measuring devices that can benefit from the systems and methods of the preferred embodiments include U.S. Patent No. 5,711,861 to Ward et al., U.S. Patent No. 6,642,015 to Vachon et al., U.S. Patent No. 6,654,625 to Say et al., U.S. Patent No. 6,514,718 to Heller, U.S. Patent No. 6,465,066 to Essenpreis et al., U.S. Patent No. 6,214,185 to Offenbacher et al., U.S. Patent No. 5,310,469 to Cunningham et al., and U.S. Patent No. 5,683,562 to Shaffer et al., for example. All of the above patents are incorporated in their entirety herein by reference and are not inclusive of all applicable analyte-measuring devices; in general, the disclosed embodiments are applicable to a variety of analyte-measuring device configurations.
[0046] The analyte-measuring device uses any known method, including invasive, minimally invasive, and non-invasive sensing techniques, to provide an output signal indicative of the concentration of the analyte. The output signal is typically a raw signal that is used to provide a useful value of the analyte to a user, such as a patient or doctor, who can use the device. In one preferred embodiment, the analyte-measuring device measures glucose using an electrochemical cell with a membrane system, such as described with reference to U.S. Patent 6,001,067 and U.S. Published Patent Application 2003/0032874, both of which are incorporated by reference herein in their entirety.
[0047] Fig. 1A is a perspective view of an implantable glucose sensor 10a in one exemplary embodiment, showing a body, an electrode system, and a membrane system incorporated thereon. Co-pending U.S. Patent Application 10/838,912, filed May 3, 2004 and entitled "IMPLANTABLE ANALYTE SENSOR," which is incorporated herein by reference in its entirety, describes systems and methods suitable for the implantable glucose sensor of the illustrated embodiment; however, one skilled in the art appreciates a variety of implantable analyte sensors that can benefit from the affinity domain of the preferred embodiments.
[0048] The body 12 is preferably formed from epoxy molded around the sensor electronics (not shown), however the body can be formed from a variety of materials, including metals, ceramics, plastics, or composites thereof. Co-pending U.S. Patent Application 10/646,333, entitled, "Optimized Device Geometry for an Implantable Glucose Device" discloses configurations suitable for the body 12, and is incorporated by reference in its entirety.
[0049] In one preferred embodiment, the sensor 10a is an enzyme-based sensor, which includes an electrode system 14a (for example, a platinum working electrode, a platinum counter electrode, and a silver/silver chloride reference electrode), which is described in more detail with reference to U.S. Patent Application 09/916,711, entitled "Sensor head for use with implantable devices," which is incorporated herein by reference in its entirety. However a variety of electrode materials and configurations can be used with the implantable glucose sensor of the preferred embodiments. The exposed electroactive surfaces of the electrode system 14a are in contact with an electrolyte phase (not shown), which is a free-flowing fluid phase disposed between a membrane system 16 and the electrode system 14a. The membrane system 16 is deposited over the electroactive surfaces of the electrode system 14a and includes a plurality of domains or layers, such as in more detail below.
[0050] In this embodiment, the counter electrode is provided to balance the current generated by the species being measured at the working electrode. In the case of a glucose oxidase based glucose sensor, the species being measured at the working electrode is H2O2. Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction:
[0051] The change in H2O2 can be monitored to determine glucose concentration because for each glucose molecule metabolized, there is a proportional change in the product H2O2. Oxidation of H2O2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H2O2, or other reducible species at the counter electrode. The H2O2 produced from the glucose oxidase reaction further reacts at the surface of working electrode and produces two protons (2H+), two electrons (2e-), and one oxygen molecule (O2).
[0052] In one embodiment, a potentiostat is employed to monitor the electrochemical reaction at the electroactive surface(s). The potentiostat applies a constant potential to the working and reference electrodes to determine a current value. The current that is produced at the working electrode (and flows through the circuitry to the counter electrode) is substantially proportional to the amount of H2O2 that diffuses to the working electrode. Accordingly, a raw signal can be produced that is representative of the concentration of glucose in the user’s body, and therefore can be utilized to estimate a meaningful glucose value.
[0053] Fig. 1B is a perspective view of an in vivo portion of a transcutaneous glucose sensor in one exemplary embodiment. Co-pending U.S. Provisional Application 60/587,787, filed July 13, 2004 and U.S. Provisional Application 60/614,683, filed September 30, 2004, describe systems and methods suitable for the transcutaneous glucose sensor of the illustrated embodiment; however, one skilled in the art appreciates a variety of transcutaneous analyte sensors that can benefit from the affinity domain of the preferred embodiments.
[0054] In this embodiment, the in vivo portion of the sensor 10b is the portion adapted for insertion under the host’s skin. Preferably, the sensor body 12b is formed from an electrode system comprising two or more electrodes: a working electrode 18 and at least one additional electrode 19, which can function as a counter and/or reference electrode, hereinafter referred to as the reference electrode. Each electrode is formed from a fine wire, with a diameter in the range of 0.001 to 0.010 inches, for example, and can be formed from plated wire or bulk material.
[0055] In one embodiment, the working electrode 18 comprises a wire formed from a conductive material, such as platinum, palladium, graphite, gold, carbon, conductive polymer, or the like. The working electrode 18 is configured and arranged to measure the concentration of an analyte. The working electrode 20 is covered with an insulating material, for example a non-conductive polymer. Dip-coating, spray-coating, or other coating or deposition techniques can be used to deposit the insulating material on the working electrode, for example. In one preferred embodiment, the insulating material comprises Parylene, which can be an advantageous conformal coating for its strength, lubricity, and electrical insulation properties, however, a variety of other insulating materials can be used, for example, fluorinated polymers, polyethyleneterephthalate, polyurethane, polyimide, or the like.
[0056] The reference electrode 19, which can function as a reference electrode alone, or as a dual reference and counter electrode, is formed from silver, Silver/Silver chloride, or the like. In one embodiment, the reference electrode 19 is formed from a flat wire with rounded edges in order to decrease sharp edges and increase host comfort. Preferably, the reference electrode 19 is juxtapositioned and/or twisted with or around the working electrode 18, however other configurations are also possible. In some embodiments, the reference electrode 19 is helically wound around the working electrode 18 (see Fig. 1B).
[0057] The assembly of wires is then optionally coated together with an insulating material, similar to that described above, in order to provide an insulating attachment. Some portion of the coated assembly structure is then stripped, for example using an excimer laser, chemical etching, or the like, to expose the necessary electroactive surfaces. In one implementation, a window 20 is formed on the insulating material to expose an electroactive surface of the working electrode 18 and at least some edges of the sensor are stripped to expose sections of electroactive surface on the reference electrode. Other methods and configurations for exposing electroactive surfaces are also possible, for example by exposing the surfaces of the working electrode 18 between the coils of the reference electrode 19. In some alternative embodiments, additional electrodes can be included within the assembly, for example, a three-electrode system (working, reference, and counter electrodes) and/or including an additional working electrode (which can be used to generate oxygen, configured as a baseline subtracting electrode, or configured for measuring additional analytes, for example).
[0058] A membrane system (not shown) is deposited over the electroactive surfaces of the sensor 10b (working electrode and optionally reference electrode) and includes a plurality of domains or layers, such as in more detail below. The membrane system can be deposited using known thin film techniques (for example, spraying, electro-depositing, dipping, or the like). In one exemplary embodiment, each domain is deposited by dipping the sensor into a solution and drawing out the sensor at a speed that provides the appropriate domain thickness. In general, the membrane system can be disposed over (deposited on) the electroactive surfaces using methods appreciated by one skilled in the art.
[0059] In the illustrated embodiment, the sensor is a glucose oxidase electrochemical sensor, wherein the working electrode 18 measures the hydrogen peroxide produced by an enzyme catalyzed reaction of the analyte being detected and creates a measurable electronic current (for example, detection of glucose utilizing glucose oxidase produces H2O2 peroxide as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2e-) and one molecule of oxygen (O2) which produces the electronic current being detected), such as described in more detail above and as is appreciated by one skilled in the art.
[0060] Preferably, the membrane system 16 described with reference to Figs. 1A and 1B provides one or more of the following functions: 1) support tissue ingrowth and encourage vascularity within the membrane, 2) block to cellular penetration, 3) protection of the exposed electrode surface from the biological environment, 4) diffusion resistance (limitation) of the analyte, 5) a catalyst for enabling an enzymatic reaction, and 6) hydrophilicity at the electrochemically reactive surfaces of the sensor interface, such as described in co-pending U.S. Patent Applications 10/838,912, filed May 3, 2004 and entitled "IMPLANTABLE ANALYTE SENSOR" and 10/885,476, filed July 6, 2004 and entitled "SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM" both of which are incorporated herein by reference in their entirety. Accordingly, membrane systems preferably include a plurality of domains or layers, for example, a cell disruptive domain, a cell impermeable domain, a resistance domain, an enzyme domain (for example, glucose oxidase), and an electrolyte domain, and can additionally include a high oxygen solubility domain (not shown), and/or a bioprotective domain (not shown), such as described in more detail in the above-cited U.S. Patent Application No. 10/838,912. However, it is understood that a membrane systems modified for other devices, for example, by including fewer or additional domains is within the scope of the preferred embodiments.
[0061] In some embodiments, the membrane system includes an interference domain that blocks some interfering species; such as described in co-pending U.S. Patent Application No. 09/916,711, entitled, "SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICES," which is incorporated herein by reference in its entirety. Membrane systems including an interference domain that can limit diffusion of high molecular weight species have been described in the prior art. The interference domain generally serve to allow analytes and other substances that are to be measured by the electrodes to pass through, while preventing passage of other substances, including interfering species, such as ascorbate and urea. In one exemplary embodiment, the interference domain is constructed from polyurethane and has a thickness of from about 0.1 to 5 microns.
[0062] Although in some embodiments, an interference domain does successfully block some interfering species described above, it does not sufficiently block other interfering species, such as acetaminophen, which is a known interferant in many hydrogen peroxide based glucose sensors. 4-Acetaminophenol (4-AAP, common name acetaminophen or paracetamol) is a nonprescription medication useful in the treatment of mild pain or fever, for example, acetaminophen can be found in Tylenol�. Acetaminophen is a common medication, and when ingested, can cause transient, signal artifacts in an electrochemical glucose sensor (see Figs. 1A and 1B, for example). Acetaminophen is only one example of an interferant that can be targeted using the affinity domain of the preferred embodiments, however.
[0063] Accordingly, in the preferred embodiments, the membrane system includes a domain that reduces the effects of transient, non-analyte related signal artifacts due to interfering species, and is hereinafter referred to as the "affinity domain." The affinity domain is adapted to sorb interfering species, such as acetaminophen, or the like, to dampen the effects of the interfering species on the signal.
[0064] In the preferred embodiments, the domains of the membrane system are formed from materials such as silicone, polytetrafluoroethylene, polyethylene-co-tetrafluoroethylene, polyolefin, polyester, polycarbonate, biostable polytetrafluoroethylene, homopolymers, copolymers, terpolymers of polyurethanes, polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers. Co-pending U. S. Patent Application 10/838,912, which is incorporated herein by reference in its entirety, describes biointerface and sensing membrane configurations and materials that can be applied to the preferred embodiments. Fig. 1C is an illustration that represents a method of forming the sensing membrane in one embodiment. Fig. 1D is a schematic side view of the sensing membrane in one embodiment. In this embodiment, the sensing membrane 88 includes a resistance domain 90, an enzyme domain 92, an interference domain 94, and an electrolyte domain 96. Preferably, the domains are serially cast upon a liner 98, and all of the domains are formed on a supporting platform 100; however, in alternative embodiments the membrane domains can be formed directly on the sensing region, for example, by spin-, spray-, or dip-coating. Alternatively, an affinity domain can be included between any layers, or within a layer, in the above-described configuration. While the above-described ordering of layers is generally preferred, other ordering can be desirable in certain embodiments. For example, the location of the interference domain or layer can be the same as that depicted in Figures 1C and 1D, or alternatively, it can be in a different location.
[0065] Much of the description of the preferred embodiments focus on providing an affinity domain with an affinity to acetaminophen, which is a known interferant in the art of amperometric glucose sensors because it generates a positive signal independent of glucose concentration. However, the affinity domain of the preferred embodiments can be implemented to include an affinity for numerous other known interferants. For example, optical glucose sensors suffer from interference from species such as triglyceride, albumin, and gamma globulin. In general, the effects of any known interferants on sensor signals can be reduced using the concepts described herein.
[0066] Fig. 2 is a graph of interferant concentration (relative) versus time (relative), which illustrates the rise and fall of a transient interferant concentration exposed to a sensor in a host’s body. For example, when acetaminophen is taken orally, the systemic concentration rises quickly and then decreases rapidly as the species is cleared by the system, such as illustrated in Fig. 2, line 22. Medication such as acetaminophen is typically taken transiently (e.g., rather than continually) and therefore produces transient, non-glucose related signal artifacts on a glucose-measuring device. Because an elevated acetaminophen concentration is a transient event in the host, moderating acetaminophen concentration is generally only required for discrete periods of time.
[0067] According to the preferred embodiments, the affinity domain has an "affinity" for the interferant to be blocked, and therefore sorbs that interferant; by sorbing the interferant into the membrane system, the effects on the resulting signal are reduced. The interferant is subsequently released from the affinity domain but at a slower rate, resulting in a lower signal at any point in time. Consequently, the local concentration of interferant presented to the electrochemically reactive surface of the sensor is moderated as illustrated in Fig. 2, line 24.
[0068] While not wishing to be bound by any particular theory, it is believed that the area under both curves is substantially equal, however the local concentration of interfering species at the sensor with the affinity domain of the preferred embodiments is sufficiently lowered over time (e.g., line 24), as compared to a membrane system without the affinity domain (e.g., line 22). In other words, the affinity domain of the preferred embodiments slows the diffusion of the interfering species on the signal, such that the signal deviation due to the interferant is below a level that can substantially interfere with sensor accuracy.
[0069] The preferred embodiments provide a membrane system, particularly for use on an electrochemical sensor, wherein the membrane system includes an affinity domain. The affinity domain can be layer, surface, region, and/or portion of the membrane system and manufactured using a variety of methods. In general, the affinity domain is formed using sorbents with an affinity for the target interferant(s). Sorbents include any substance (e.g., molecule, particle, coating, or the like) that has a stronger affinity for a particular molecule or compound (e.g., interfering species) than another (e.g., measured analyte or substance). The sorbents of the preferred embodiments provide for the retention of an interfering species, such that the interfering species will be at least temporarily immobilized, and will take a longer time to pass through the affinity domain.
[0070] In some embodiments, the sorbents are polymeric adsorbents, such as chromatography-packing materials. The chromatography-packing materials can be selected, modified, or otherwise adapted to possess an affinity for a target interferant, for example, phenol-containing species. Some examples of chromatography-packing materials include Optipore L-493 (Dow Chemical Company, Providence, RI), SP-850 (Mitsubishi Chemical America, White Plains, NY), Amberlite XAD-4 (Rohm and Haas, Philadelphia, PA), and LC-18 (Supleco, Bellefonte, Pennsylvania).
[0071] In some embodiments, fused silica, Amberlite XAD-2, Amberlite IRC-50, Discovery DPA-6s, C-6 Bulk Phenyl, and other affinity-based packings or adsorbents synthesized from fused silica and/or TEOS with different phenyl derivatized silanes, can be used as the sorbents. In some embodiments, the sorbents are formed from carbon-based solids.
[0072] In some embodiments, sorbents are coated onto an inert support material, such as treated diatomaceous earth or other silica based materials (for example, solid silica support particles can have an organic coating bonded to their surface, wherein the bonding is produced by reacting a halogen substituted organosilane with the surface –OH groups present on the silica support). Generally, these coatings are non-polar in nature and therefore retention of the interfering species is produced by dispersion forces, making them useful for separation of organic compounds based on slight differences in their backbone or side chain configuration.
[0073] In some embodiments, the affinity domain can be manufactured using molecular imaging technology. In this embodiment, a sorbent is selected or prepared that is useful for binding a pre-determined interferant on the surface of a material by complementary functional group interaction. For example, a cross-linked styrene divinyl benzene material can be prepared that is imprinted with acetaminophen. U.S. Patents 5,453,199 and 5,872,198, both of which are incorporated by reference herein in their entirety, describe molecular imaging technology that can be used for imprinting acetaminophen or other interferants on the surface of a material. Complementary functional group interaction provides a selective, reversible association between the interferant and the material surface. Such methods for making binding surfaces are referred to hereinafter as "molecular imaging" methods and form surfaces referred to hereinafter as "imaged surfaces."
[0074] Molecular imaging provides a high surface area chromatography matrix material with molecular-specific sorbents. The imaged surfaces bind with interferants by covalently adhering, in a way that is geometrically controlled at least in the direction parallel, and preferably also in a direction normal to an underlying surface plane, a plurality of charged groups, hydrophobic groups, and various combinations thereof, to form a mirror image of groups complementary to them on a molecular surface of a target molecule, for example acetaminophen. These groups are preferably spaced about a hydrophilic undersurface rich in hydrogen containing groups and electronegative atoms such as oxygen, nitrogen, phosphorus, or sulfur that take part in formation of hydrogen bonds.
[0075] In some embodiments, a silica-like sol-gel material is imaged similarly to that described above with reference to molecular imaging. U.S. Patent 6,057,377, which is incorporated herein by reference in its entirety, describes a method for molecularly imprinting the surface of a sol-gel material, by forming a solution including a sol-gel material, a solvent, an imprinting molecule, and a functionalizing siloxane monomer of the form Si(OR)3-n Xn, wherein n is an integer between zero and three and X is a functional group capable of reacting or associating with the imprinting molecule. In some embodiments, the phenyl silane bisphenyldimethylpropytrimethoxysilane, N-phenylaminopropyltrimethoxysilane, phenyldiethoxysilane, or phenyltriethoxysilane, for example.
[0076] The resulting sol-gel structure would include a three dimensional material imprinted with acetaminophen or other interferant. In this embodiment, the solvent is evaporated, and the imprinting molecule removed to form the molecularly imprinted sol-gel material. The removal of the imprinting molecule creates a pocket, which has the correct geometry and hydrogen binding to bind the interfering species as it passes through the structure. This sol-gel structure can then be ground using a mortar-pestle, or the like, and added to the membrane system as the affinity domain.
[0077] The use of sol-gel materials advantageously allow the material porosity, pore size, density, surface area, hardness, electrostatic charge, polarity, optical density, and surface hydrophobicity to be tailored to suit the affinity domain useful in the preferred embodiments.
[0078] An affinity domain of the preferred embodiments was prepared by blending chromatographic packings into a selected material and then cured. Particularly, chromatographic packings (Optipore L-493, Dow Chemical Company, Providence, RI) were ground and mixed 10% by weight with a polyurethane dispersion (Bayhydrol 123, Bayer, Pittsburgh, PA) and cast onto a carrier layer (ChronoThaneTM H, CM Biomaterials, Woburn, MA). This affinity domain was then laminated onto a membrane system including a resistance domain, enzyme domain, interference domain, and electrolyte domain such as described in U.S. Patent 6,001,067, which is incorporated herein by reference in its entirety. The membrane system was placed on glucose sensors such as described with reference to Fig. 1A, above, and glucose and acetaminophen tests were performed.
[0079] Fig. 3 is a graph of the response of test and control glucose sensors to glucose and acetaminophen standard step concentrations, including two glucose sensors each with a control membrane system and two glucose sensors each with a test multilayer membrane including an affinity domain of the preferred embodiments. The control sensors ("W55-4Layer/Lam-D100-123-Control") included a membrane system with a resistance domain, enzyme domain, interference domain, and electrolyte domain such as described in U.S. Patent 6,001,067. The test sensors ("W55-4Layer/Lam-D100-L493-123") included the control membrane system with an affinity domain laminated thereon. The affinity domain was prepared as described in this experiment. The x-axis represents time in hours. The y-axis represents calibrated glucose sensor signal strength in mg/dL.
[0080] Initially, the glucose sensors were placed in phosphate buffer and allowed to equilibrate for 15 minutes. Glucose was then added to a concentration of 200 mg/dL. The glucose sensor responses are shown on the graph by calibrated glucose sensor signals for each of the four sensors up to an approximate reading of 200 mg/dL after about one hour (Fig. 3, at t≈1.5), indicating functional glucose sensors. The solution was then changed to a buffer with a glucose concentration of 0 mg/dL and the calibrated sensor signals returned to approximately 0 mg/dL. After one and one-half hours in buffer (Fig. 3, at t≈3.5), acetaminophen was added to a concentration of 200 mM. After approximately one hour of exposure to the 200mM acetaminophen (Fig. 3, at t≈4.5), the control sensors showed calibrated glucose sensor signals up to about 75 to 120 mg/dL, indicating the sensitivity of the control sensors to acetaminophen as an interferant. However, the test sensors, including the affinity domain of the preferred embodiments, showed significantly reduced sensitivity to the acetaminophen concentration as compared to the control membranes (for example, test signals of less than about 40 mg/dL). After the hour of acetaminophen exposure (Fig. 3, at t≈4.5), the sensors were returned to buffer. The signal associated with the control sensors quickly returned back to zero, however the test sensors showed a slower return to zero signal strength.
[0081] These data show that the use of an affinity domain of the preferred embodiments provides significant dampening of the signal due to interferants as compared to membrane systems without the affinity domain. Thus, the release of the interferant from the affinity domain is sufficiently lowered and distributed over time, as compared to a membrane system without the affinity domain of the preferred embodiments, such that the effective local concentration of the interferant at the sensor head is below a level that can substantially interfere with sensor accuracy.
[0082] Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in co-pending U.S. Patent Application No. 10/885,476 filed July 6, 2004 and entitled "SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM"; U.S. Patent Application No. 10/842,716, filed May 10, 2004 and entitled, "MEMBRANE SYSTEMS INCORPORATING BIOACTIVE AGENTS"; co-pending U.S. Patent Application No. 10/838,912 filed May 3, 2004 and entitled, "IMPLANTABLE ANALYTE SENSOR"; U.S. Patent Application No. 10/789,359 filed February 26, 2004 and entitled, "INTEGRATED DELIVERY DEVICE FOR A CONTINUOUS GLUCOSE SENSOR"; U.S. Application No. 10/685,636 filed October 28, 2003 and entitled, "SILICONE COMPOSITION FOR MEMBRANE SYSTEM"; U.S. Application No. 10/648,849 filed August 22, 2003 and entitled, "SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM"; U.S. Application No. 10/646,333 filed August 22, 2003 entitled, "OPTIMIZED SENSOR GEOMETRY FOR AN IMPLANTABLE GLUCOSE SENSOR"; U.S. Application No. 10/647,065 filed August 22, 2003 entitled, "POROUS MEMBRANES FOR USE WITH IMPLANTABLE DEVICES"; U.S. Application No. 10/633,367 filed August 1, 2003 entitled, "SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA"; U.S. Patent No. 6,702,857 entitled "MEMBRANE FOR USE WITH IMPLANTABLE DEVICES"; U.S. Appl. No. 09/916,711 filed July 27, 2001 and entitled "SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICE"; U.S. Appl. No. 09/447,227 filed November 22, 1999 and entitled "DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS"; U.S. Appl. No. 10/153,356 filed May 22, 2002 and entitled "TECHNIQUES TO IMPROVE POLYURETHANE MEMBRANES FOR IMPLANTABLE GLUCOSE SENSORS"; U.S. Appl. No. 09/489,588 filed January 21, 2000 and entitled "DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS"; U.S. Appl. No. 09/636,369 filed August 11, 2000 and entitled "SYSTEMS AND METHODS FOR REMOTE MONITORING AND MODULATION OF MEDICAL DEVICES"; and U.S. Appl. No. 09/916,858 filed July 27, 2001 and entitled "DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS," as well as issued patents including U.S. 6,001,067 issued December 14, 1999 and entitled "DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS"; U.S. 4,994,167 issued February 19, 1991 and entitled "BIOLOGICAL FLUID MEASURING DEVICE"; and U.S. 4,757,022 filed July 12, 1988 and entitled "BIOLOGICAL FLUID MEASURING DEVICE"; U.S. Appl. No. 60/489,615 filed July 23, 2003 and entitled "ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE"; U.S. Appl. No. 60/490,010 filed July 25, 2003 and entitled "INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE ASSEMBLY"; U.S. Appl. No. 60/490,009 filed July 25, 2003 and entitled "OXYGEN ENHANCING ENZYME MEMBRANE FOR ELECTROCHEMICAL SENSORS"; U.S. Appl. No. 10/896,312 filed July 21, 2004 and entitled "OXYGEN-GENERATING ELECTRODE FOR USE IN ELECTROCHEMICAL SENSORS"; U.S. Appl. No. 10/896,637 filed July 21, 2004 and entitled "ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE"; U.S. Appl. No. 10/896,772 filed July 21, 2004 and entitled "INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE ASSEMBLY"; U.S. Appl. No. 10/896,639 filed July 21, 2004 and entitled "OXYGEN ENHANCING ENZYME MEMBRANE FOR ELECTROCHEMICAL SENSORS"; U.S. Appl. No. 10/897,377 filed July 21, 2004 and entitled "ELECTROCHEMICAL SENSORS INCLUDING ELECTRODE SYSTEMS WITH INCREASED OXYGEN GENERATION". The foregoing patent applications and patents are incorporated herein by reference in their entireties.
[0083] All references cited herein are incorporated herein by reference in their entireties. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
[0084] The term "comprising" as used herein is synonymous with "including," "containing," or "characterized by," and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.
[0085] All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term "about." Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.
[0086] The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention as embodied in the attached claims.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3966580 *Sep 16, 1974Jun 29, 1976The University Of UtahNovel protein-immobilizing hydrophobic polymeric membrane, process for producing same and apparatus employing sameUS4040908 *Mar 12, 1976Aug 9, 1977Children's Hospital Medical CenterPolarographic analysis of cholesterol and other macromolecular substancesUS4073713 *Jul 26, 1976Feb 14, 1978The Yellow Springs Instrument Company, Inc.Membrane for enzyme electrodesUS4388166 *May 15, 1982Jun 14, 1983Tokyo Shibaura Denki Kabushiki KaishaElectrochemical measuring apparatus provided with an enzyme electrodeUS4436094 *Jan 27, 1982Mar 13, 1984Evreka, Inc.Monitor for continuous in vivo measurement of glucose concentrationUS4534355 *Oct 13, 1981Aug 13, 1985Smith And Nephew Associated Companies Inc.Electrochemical sensor employing a gas-permeable hydrophilic polyurethane membraneUS4650547 *Dec 20, 1985Mar 17, 1987The Regents Of The University Of CaliforniaMethod and membrane applicable to implantable sensorUS4663824 *Jul 5, 1984May 12, 1987Matsushita Electric Industrial Co., Ltd.Aluminum electrolytic capacitor and a manufacturing method thereforUS4671288 *Jun 13, 1985Jun 9, 1987The Regents Of The University Of CaliforniaElectrochemical cell sensor for continuous short-term use in tissues and bloodUS4686309 *Feb 15, 1985Aug 11, 1987Rhone-Poulenc Sante3-phenyl-2-propeneamine derivatives, their preparation and compositions containing themUS4757022 *Nov 19, 1987Jul 12, 1988Markwell Medical Institute, Inc.Biological fluid measuring deviceUS4759828 *Apr 9, 1987Jul 26, 1988Nova Biomedical CorporationGlucose electrode and method of determining glucoseUS4810470 *Jun 19, 1987Mar 7, 1989Miles Inc.Volume independent diagnostic deviceUS4861830 *Jun 22, 1987Aug 29, 1989Th. Goldschmidt AgPolymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for formingUS4890620 *Feb 17, 1988Jan 2, 1990The Regents Of The University Of CaliforniaTwo-dimensional diffusion glucose substrate sensing electrodeUS4927407 *Jun 19, 1989May 22, 1990Regents Of The University Of MinnesotaCardiac assist pump with steady rate supply of fluid lubricantUS4994167 *Jul 7, 1988Feb 19, 1991Markwell Medical Institute, Inc.Biological fluid measuring deviceUS5030333 *Oct 14, 1986Jul 9, 1991Children's Hospital Medical CenterPolarographic method for measuring both analyte and oxygen with the same detecting electrode of an electroenzymatic sensorUS5140985 *Oct 21, 1991Aug 25, 1992Schroeder Jon MNoninvasive blood glucose measuring deviceUS5235003 *Aug 31, 1990Aug 10, 1993Thoratec Laboratories CorporationPolysiloxane-polylactone block copolymersUS5322063 *Oct 4, 1991Jun 21, 1994Eli Lilly And CompanyHydrophilic polyurethane membranes for electrochemical glucose sensorsUS5397848 *May 21, 1993Mar 14, 1995Allergan, Inc.Enhancing the hydrophilicity of silicone polymersUS5411647 *Jan 25, 1994May 2, 1995Eli Lilly And CompanyTechniques to improve the performance of electrochemical sensorsUS5428123 *Apr 23, 1993Jun 27, 1995The Polymer Technology GroupCopolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight rangeUS5431160 *Nov 9, 1993Jul 11, 1995University Of New MexicoMiniature implantable refillable glucose sensor and material thereforUS5438984 *Mar 30, 1993Aug 8, 1995Sudor PartnersApparatus and method for the collection of analytes on a dermal patchUS5496453 *Oct 12, 1994Mar 5, 1996Kyoto Daiichi Kagaku Co., Ltd.Biosensor and method of quantitative analysis using the sameUS5497772 *Nov 19, 1993Mar 12, 1996Alfred E. Mann Foundation For Scientific ResearchGlucose monitoring systemUS5540828 *Feb 15, 1994Jul 30, 1996Yacynych; AlexanderMethod for making electrochemical sensors and biosensors having a polymer modified surfaceUS5630978 *Jun 7, 1995May 20, 1997Yissum Research Development Co. Of The Hebrew University Of JerusalemPreparation of biologically active molecules by molecular imprintingUS5641539 *Jun 1, 1995Jun 24, 1997Perseptive Biosystems, Inc.Molecular imagingUS5711861 *Nov 22, 1995Jan 27, 1998Ward; W. KennethDevice for monitoring changes in analyte concentrationUS5756632 *Jun 2, 1995May 26, 1998The Polymer Technology GroupSystems for premeating molecules of predetermined molecular weight rangeUS5776324 *May 17, 1996Jul 7, 1998Encelle, Inc.Electrochemical biosensorsUS5777060 *Sep 26, 1996Jul 7, 1998Minimed, Inc.Silicon-containing biocompatible membranesUS5783054 *Apr 9, 1997Jul 21, 1998Australian Membrane And Biotechnology Research InstituteMethod for producing improved sensorUS5791344 *Jan 4, 1996Aug 11, 1998Alfred E. Mann Foundation For Scientific ResearchPatient monitoring systemUS5795774 *Jul 10, 1997Aug 18, 1998Nec CorporationBiosensorUS5858296 *May 16, 1997Jan 12, 1999Yissum Research Development Co. Of The Hebrew University Of JerusalemPreparation of biologically active molecules by molecular imprintingUS5871514 *Aug 1, 1997Feb 16, 1999Medtronic, Inc.Attachment apparatus for an implantable medical device employing ultrasonic energyUS5872198 *May 27, 1997Feb 16, 1999Mosbach; KlausMolecularly imprinted beaded polymers and stabilized suspension polymerization of the same in perfluorocarbon liquidsUS5882494 *Aug 28, 1995Mar 16, 1999Minimed, Inc.Polyurethane/polyurea compositions containing silicone for biosensor membranesUS5897578 *Aug 27, 1998Apr 27, 1999Medtronic, Inc.Attachment apparatus and method for an implantable medical device employing ultrasonic energyUS5910554 *Jun 14, 1996Jun 8, 1999Regents Of The University Of MinnesotaHighly cross-linked polymeric supportsUS5914026 *Jan 6, 1997Jun 22, 1999Implanted Biosystems Inc.Implantable sensor employing an auxiliary electrodeUS5916445 *Oct 13, 1997Jun 29, 1999Bio-Rad Laboratories, Inc.Selective recognition of solutes in chromatographic media by artificially created affinityUS5919215 *Aug 27, 1998Jul 6, 1999Medtronic, Inc.Attachment apparatus for an implantable medical device employing ultrasonic energyUS5935785 *Apr 30, 1997Aug 10, 1999Motorola, Inc.Binding assay methodsUS6011984 *Nov 21, 1996Jan 4, 2000Minimed Inc.Detection of biological molecules using chemical amplification and optical sensorsUS6017435 *May 10, 1996Jan 25, 2000Imperial College Of Science, Technology And MedicineMolecular imagingUS6046448 *May 21, 1998Apr 4, 2000Seiko Instruments Inc.Scanning near field optical microscope based on the use of polarized lightUS6048691 *May 20, 1997Apr 11, 2000Motorola, Inc.Method and system for performing a binding assayUS6051372 *Sep 9, 1997Apr 18, 2000Nimbus Biotechnologie GmbhTemplate induced patterning of surfaces and their reversible stabilization using phase transitions of the patterned materialUS6057377 *Oct 30, 1998May 2, 2000Sandia CorporationMolecular receptors in metal oxide sol-gel materials prepared via molecular imprintingUS6081736 *Oct 20, 1997Jun 27, 2000Alfred E. Mann FoundationImplantable enzyme-based monitoring systems adapted for long term useUS6083710 *Jun 16, 1999Jul 4, 2000E. Heller & CompanyElectrochemical analyte measurement systemUS6088608 *Oct 20, 1997Jul 11, 2000Alfred E. Mann FoundationElectrochemical sensor and integrity tests thereforUS6103033 *Mar 4, 1998Aug 15, 2000Therasense, Inc.Process for producing an electrochemical biosensorUS6103533 *May 10, 1996Aug 15, 2000Imperial College Of Science, Technology And MedicineMolecular imagingUS6107083 *Aug 21, 1998Aug 22, 2000Bayer CorporationOptical oxidative enzyme-based sensorsUS6175752 *Apr 30, 1998Jan 16, 2001Therasense, Inc.Analyte monitoring device and methods of useUS6200772 *Aug 17, 1998Mar 13, 2001Sensalyse Holdings LimitedModified polyurethane membrane sensors and analytical methodsUS6214185 *Apr 16, 1998Apr 10, 2001Avl Medical InstrumentsSensor with PVC cover membraneUS6232783 *Jun 15, 1999May 15, 2001John H. MerrillMethod for monitoring an aqueous flow using selective filmUS6241863 *Apr 27, 1999Jun 5, 2001Harold G. MonbouquetteAmperometric biosensors based on redox enzymesUS6251280 *Sep 15, 1999Jun 26, 2001University Of Tennessee Research CorporationImprint-coating synthesis of selective functionalized ordered mesoporous sorbents for separation and sensorsUS6259937 *Jun 19, 1998Jul 10, 2001Alfred E. Mann FoundationImplantable substrate sensorUS6274285 *Nov 12, 1999Aug 14, 2001Agfa-Gevaert NvRadiation-sensitive recording material for the production of driographic offset printing platesUS6343225 *Sep 14, 1999Jan 29, 2002Implanted Biosystems, Inc.Implantable glucose sensorUS6356776 *Aug 16, 2000Mar 12, 2002Cygnus, Inc.Device for monitoring of physiological analytesUS6368274 *May 8, 2000Apr 9, 2002Medtronic Minimed, Inc.Reusable analyte sensor site and method of using the sameUS6372244 *Aug 25, 2000Apr 16, 2002Islet Sheet Medical, Inc.Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their useUS6400974 *Jun 29, 2000Jun 4, 2002Sensors For Medicine And Science, Inc.Implanted sensor processing system and method for processing implanted sensor outputUS6409674 *Sep 24, 1998Jun 25, 2002Data Sciences International, Inc.Implantable sensor with wireless communicationUS6546268 *Jun 2, 2000Apr 8, 2003Ball Semiconductor, Inc.Glucose sensorUS6560471 *Jan 2, 2001May 6, 2003Therasense, Inc.Analyte monitoring device and methods of useUS6565509 *Sep 21, 2000May 20, 2003Therasense, Inc.Analyte monitoring device and methods of useUS6702857 *Jul 27, 2001Mar 9, 2004Dexcom, Inc.Membrane for use with implantable devicesUS6721587 *Feb 15, 2002Apr 13, 2004Regents Of The University Of CaliforniaMembrane and electrode structure for implantable sensorUS6741877 *Jan 21, 2000May 25, 2004Dexcom, Inc.Device and method for determining analyte levelsUS6862465 *Jul 27, 2001Mar 1, 2005Dexcom, Inc.Device and method for determining analyte levelsUS6892085 *Nov 26, 2002May 10, 2005Medtronic Minimed, Inc.Glucose sensor package systemUS6895263 *May 8, 2002May 17, 2005Medtronic Minimed, Inc.Real time self-adjusting calibration algorithmUS7074307 *Jul 21, 2004Jul 11, 2006Dexcom, Inc.Electrode systems for electrochemical sensorsUS20030032874 *Jul 27, 2001Feb 13, 2003Dexcom, Inc.Sensor head for use with implantable devicesUS20030070548 *Nov 21, 2002Apr 17, 2003Lydia ClausenSensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensorUS20040045879 *Sep 9, 2003Mar 11, 2004Dexcom, Inc.Device and method for determining analyte levelsUS20040106857 *Nov 20, 2003Jun 3, 2004Regents Of The University Of CaliforniaMembrane and electrode structure for implantable sensorUS20050027180 *Aug 1, 2003Feb 3, 2005Goode Paul V.System and methods for processing analyte sensor dataUS20050027181 *Aug 1, 2003Feb 3, 2005Goode Paul V.System and methods for processing analyte sensor dataUS20050027463 *Aug 1, 2003Feb 3, 2005Goode Paul V.System and methods for processing analyte sensor dataUS20050031689 *May 10, 2004Feb 10, 2005Dexcom, Inc.Biointerface membranes incorporating bioactive agentsUS20050033132 *May 14, 2004Feb 10, 2005Shults Mark C.Analyte measuring deviceUS20050043598 *Aug 22, 2003Feb 24, 2005Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS20050051440 *Jul 21, 2004Mar 10, 2005Simpson Peter C.Electrochemical sensors including electrode systems with increased oxygen generationUS20050054909 *Jul 21, 2004Mar 10, 2005James PetisceOxygen enhancing membrane systems for implantable devicesUS20050056552 *Jul 21, 2004Mar 17, 2005Simpson Peter C.Increasing bias for oxygen production in an electrode systemUS20050090607 *Oct 28, 2003Apr 28, 2005Dexcom, Inc.Silicone composition for biocompatible membraneUS20060015020 *Jul 6, 2004Jan 19, 2006Dexcom, Inc.Systems and methods for manufacture of an analyte-measuring device including a membrane system* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS7299082Oct 27, 2004Nov 20, 2007Abbott Diabetes Care, Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS7651596Jan 26, 2010Dexcom, Inc.Cellulosic-based interference domain for an analyte sensorUS7653425Jan 26, 2010Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS7654956Feb 2, 2010Dexcom, Inc.Transcutaneous analyte sensorUS7679407Apr 27, 2004Mar 16, 2010Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systemsUS7697967Sep 28, 2006Apr 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS7722536Jul 14, 2004May 25, 2010Abbott Diabetes Care Inc.Glucose measuring device integrated into a holster for a personal area network deviceUS7727181Apr 13, 2005Jun 1, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS7731657Aug 30, 2005Jun 8, 2010Abbott Diabetes Care Inc.Analyte sensor introducer and methods of useUS7736310Jan 30, 2006Jun 15, 2010Abbott Diabetes Care Inc.On-body medical device securementUS7753873 *Dec 29, 2008Jul 13, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS7753874 *Jul 13, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS7756561Sep 30, 2005Jul 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systemsUS7761130 *Jul 20, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7766829Nov 4, 2005Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS7766864 *Dec 29, 2008Aug 3, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS7768386Jul 31, 2007Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS7768387Apr 14, 2008Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7768408May 17, 2006Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS7771352May 1, 2008Aug 10, 2010Dexcom, Inc.Low oxygen in vivo analyte sensorUS7783333Mar 10, 2005Aug 24, 2010Dexcom, Inc.Transcutaneous medical device with variable stiffnessUS7792562Sep 7, 2010Dexcom, Inc.Device and method for determining analyte levelsUS7801582Mar 31, 2006Sep 21, 2010Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS7811231Oct 12, 2010Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS7822455Oct 26, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7826382Nov 2, 2010Abbott Diabetes Care Inc.Close proximity communication device and methodsUS7826879Feb 28, 2006Nov 2, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7828728Feb 14, 2007Nov 9, 2010Dexcom, Inc.Analyte sensorUS7831287Nov 9, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7835777Nov 16, 2010Dexcom, Inc.Device and method for determining analyte levelsUS7857760Feb 22, 2006Dec 28, 2010Dexcom, Inc.Analyte sensorUS7860544Mar 7, 2007Dec 28, 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7869853Jan 11, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7883464Sep 30, 2005Feb 8, 2011Abbott Diabetes Care Inc.Integrated transmitter unit and sensor introducer mechanism and methods of useUS7884729Aug 2, 2010Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS7885697Feb 8, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7885698Feb 28, 2006Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS7885699Feb 8, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7896809Nov 3, 2008Mar 1, 2011Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7899511Jan 17, 2006Mar 1, 2011Dexcom, Inc.Low oxygen in vivo analyte sensorUS7901354May 1, 2008Mar 8, 2011Dexcom, Inc.Low oxygen in vivo analyte sensorUS7905833Jun 21, 2005Mar 15, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7920907Jun 7, 2007Apr 5, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodUS7922458Dec 29, 2008Apr 12, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7928850Apr 19, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS7946984May 24, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7948369Aug 2, 2010May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7948370Aug 14, 2009May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systemsUS7949381Apr 11, 2008May 24, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7951080May 31, 2011Abbott Diabetes Care Inc.On-body medical device securementUS7970448Jun 28, 2011Dexcom, Inc.Device and method for determining analyte levelsUS7974672Jul 5, 2011Dexcom, Inc.Device and method for determining analyte levelsUS7976778Jul 12, 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS7981034Feb 28, 2006Jul 19, 2011Abbott Diabetes Care Inc.Smart messages and alerts for an infusion delivery and management systemUS7993108Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7993109Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7996054Aug 9, 2011Abbott Diabetes Care Inc.Electrochemical analyte sensorUS7996158May 14, 2008Aug 9, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8029245Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8029250Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8029441Feb 28, 2006Oct 4, 2011Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS8029443Sep 26, 2008Oct 4, 2011Abbott Diabetes Care Inc.Glucose measuring device integrated into a holster for a personal area network deviceUS8029459Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8029460Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8047811Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8047812Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8050731Nov 1, 2011Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8053018Jan 15, 2010Nov 8, 2011Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8064977Jul 29, 2009Nov 22, 2011Dexcom, Inc.Silicone based membranes for use in implantable glucose sensorsUS8066639Jun 4, 2004Nov 29, 2011Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8085151Jun 26, 2008Dec 27, 2011Abbott Diabetes Care Inc.Signal converting cradle for medical condition monitoring and management systemUS8086292Oct 27, 2009Dec 27, 2011Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8089363Jan 3, 2012Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8103456Jan 24, 2012Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8103471May 14, 2008Jan 24, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8112138Sep 26, 2008Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systemsUS8112240Apr 29, 2005Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systemsUS8115635Nov 24, 2009Feb 14, 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxesUS8116840Oct 30, 2007Feb 14, 2012Abbott Diabetes Care Inc.Method of calibrating of an analyte-measurement device, and associated methods, devices and systemsUS8121857Feb 14, 2008Feb 21, 2012Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8123686Mar 1, 2007Feb 28, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS8133178Feb 22, 2006Mar 13, 2012Dexcom, Inc.Analyte sensorUS8135548Oct 26, 2007Mar 13, 2012Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8140142Apr 14, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS8140312Jan 31, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8149103May 23, 2011Apr 3, 2012Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8149117Aug 29, 2009Apr 3, 2012Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8160670Jul 3, 2008Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agentUS8160671Apr 17, 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8160900Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring and management device and method to analyze the frequency of user interaction with the deviceUS8162829Mar 30, 2009Apr 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8175673Nov 9, 2009May 8, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8177716Dec 21, 2009May 15, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8185181May 22, 2012Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS8187183Oct 11, 2010May 29, 2012Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8206296Jun 26, 2012Abbott Diabetes Care Inc.Method and system for providing integrated analyte monitoring and infusion system therapy managementUS8211016Jul 3, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8216137Jul 20, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8216138Jul 10, 2012Abbott Diabetes Care Inc.Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentrationUS8219173Sep 30, 2008Jul 10, 2012Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8219174Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8219175Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8223021Jul 17, 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxesUS8224413Oct 10, 2008Jul 17, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8224415Jan 29, 2009Jul 17, 2012Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8226555Mar 18, 2009Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226557Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226558Sep 27, 2010Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226891Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8229534Jul 24, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8229535Jul 24, 2012Dexcom, Inc.Systems and methods for blood glucose monitoring and alert deliveryUS8231531Jul 31, 2012Dexcom, Inc.Analyte sensorUS8231532Apr 30, 2007Jul 31, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8235896Dec 21, 2009Aug 7, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8236242Feb 12, 2010Aug 7, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8239166Aug 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8249684Aug 21, 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8252229Apr 10, 2009Aug 28, 2012Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8255030Apr 25, 2006Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8255031Mar 17, 2009Aug 28, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8255032Jan 15, 2010Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8255033Apr 25, 2006Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8260392Sep 4, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8260558May 14, 2008Sep 4, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8265726Sep 11, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8268243Dec 28, 2009Sep 18, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8273022Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8273295Nov 24, 2009Sep 25, 2012Abbott Diabetes Care Inc.Apparatus for providing power management in data communication systemsUS8275437Mar 23, 2007Sep 25, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8275439Nov 9, 2009Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8277713May 3, 2004Oct 2, 2012Dexcom, Inc.Implantable analyte sensorUS8280475Feb 23, 2009Oct 2, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8287453Nov 7, 2008Oct 16, 2012Dexcom, Inc.Analyte sensorUS8287454Oct 16, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8290559Oct 24, 2008Oct 16, 2012Dexcom, Inc.Systems and methods for processing sensor dataUS8306598Nov 9, 2009Nov 6, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8333714Sep 10, 2006Dec 18, 2012Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8343092Nov 24, 2009Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8343093May 28, 2010Jan 1, 2013Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS8344966Jan 31, 2006Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic deviceUS8346335Jan 1, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8346336Mar 18, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8346337Jun 30, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8353829Dec 21, 2009Jan 15, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8353881Dec 28, 2005Jan 15, 2013Abbott Diabetes Care Inc.Infusion sets for the delivery of a therapeutic substance to a patientUS8357091Jan 22, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8358210Jan 22, 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxesUS8362904Jan 29, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8364229Jan 29, 2013Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noiseUS8366614Mar 30, 2009Feb 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8368556Feb 5, 2013Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8372005Dec 21, 2009Feb 12, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8374668Oct 23, 2008Feb 12, 2013Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS8376945Nov 23, 2009Feb 19, 2013Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS8377031Aug 31, 2008Feb 19, 2013Abbott Diabetes Care Inc.Closed loop control system with safety parameters and methodsUS8380273Feb 19, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8386004Feb 26, 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8390455Mar 5, 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxesUS8391945Mar 17, 2009Mar 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8394021Mar 12, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8409093Apr 2, 2013Abbott Diabetes Care Inc.Assessing measures of glycemic variabilityUS8409131Mar 7, 2007Apr 2, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8417312Oct 24, 2008Apr 9, 2013Dexcom, Inc.Systems and methods for processing sensor dataUS8417545Apr 9, 2013Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8423114Oct 1, 2007Apr 16, 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8427298Apr 23, 2013Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8428678Apr 23, 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8437966May 7, 2013Abbott Diabetes Care Inc.Method and system for transferring analyte test dataUS8444560May 14, 2008May 21, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8452368May 28, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8456301May 8, 2008Jun 4, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8457708Jun 4, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8460243Jun 10, 2003Jun 11, 2013Abbott Diabetes Care Inc.Glucose measuring module and insulin pump combinationUS8461985May 8, 2008Jun 11, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8463351Aug 6, 2010Jun 11, 2013Abbott Diabetes Care Inc.Electrochemical analyte sensorUS8465425Jun 18, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8467972Jun 18, 2013Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysisUS8471714Dec 30, 2011Jun 25, 2013Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8473021Jul 31, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8473022Jan 30, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS8473220Jan 23, 2012Jun 25, 2013Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8475373Jul 17, 2008Jul 2, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8478557Jul 30, 2010Jul 2, 2013Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8480580Apr 19, 2007Jul 9, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8483791Apr 11, 2008Jul 9, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8483793Oct 29, 2010Jul 9, 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8483967Apr 28, 2010Jul 9, 2013Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS8483974Nov 20, 2009Jul 9, 2013Abbott Diabetes Care Inc.Method and system for transferring analyte test dataUS8484005Mar 19, 2012Jul 9, 2013Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8497777Apr 15, 2010Jul 30, 2013Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8502682Dec 23, 2011Aug 6, 2013Abbott Diabetes Care Inc.Signal converting cradle for medical condition monitoring and management systemUS8506482Feb 7, 2011Aug 13, 2013Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS8509107Nov 1, 2010Aug 13, 2013Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8509871Oct 28, 2008Aug 13, 2013Dexcom, Inc.Sensor head for use with implantable devicesUS8512239Apr 20, 2009Aug 20, 2013Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8512243Sep 30, 2005Aug 20, 2013Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of useUS8512244Sep 26, 2008Aug 20, 2013Abbott Diabetes Care Inc.Integrated analyte sensor and infusion device and methods thereforUS8512246Mar 15, 2010Aug 20, 2013Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systemsUS8514086Aug 30, 2010Aug 20, 2013Abbott Diabetes Care Inc.Displays for a medical deviceUS8515517Sep 30, 2009Aug 20, 2013Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS8515518Dec 28, 2005Aug 20, 2013Abbott Diabetes Care Inc.Analyte monitoringUS8515519Feb 26, 2009Aug 20, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8527025Nov 22, 1999Sep 3, 2013Dexcom, Inc.Device and method for determining analyte levelsUS8532935Jul 16, 2012Sep 10, 2013Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8542122Jan 17, 2013Sep 24, 2013Abbott Diabetes Care Inc.Glucose measurement device and methods using RFIDUS8543183Dec 23, 2011Sep 24, 2013Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8543184Oct 20, 2011Sep 24, 2013Dexcom, Inc.Silicone based membranes for use in implantable glucose sensorsUS8545403Dec 28, 2006Oct 1, 2013Abbott Diabetes Care Inc.Medical device insertionUS8560038May 14, 2008Oct 15, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8560039Sep 17, 2009Oct 15, 2013Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensorsUS8560082Jan 30, 2009Oct 15, 2013Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processingUS8560250Aug 18, 2010Oct 15, 2013Abbott LaboratoriesMethod and system for transferring analyte test dataUS8562558Jun 5, 2008Oct 22, 2013Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensorUS8565848May 7, 2009Oct 22, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8571624Dec 29, 2004Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for mounting a data transmission device in a communication systemUS8571808Jan 23, 2012Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8579853Oct 31, 2006Nov 12, 2013Abbott Diabetes Care Inc.Infusion devices and methodsUS8583204Mar 5, 2010Nov 12, 2013Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8583205Apr 16, 2010Nov 12, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8585591Jul 10, 2010Nov 19, 2013Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS8588881Mar 2, 2007Nov 19, 2013Abbott Diabetes Care Inc.Subcutaneous glucose electrodeUS8591410Jun 1, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8591455Feb 20, 2009Nov 26, 2013Dexcom, Inc.Systems and methods for customizing delivery of sensor dataUS8593109Nov 3, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8593287Jul 20, 2012Nov 26, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8597188Jun 20, 2008Dec 3, 2013Abbott Diabetes Care Inc.Health management devices and methodsUS8597189Mar 3, 2009Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8597575Jul 23, 2012Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8600681May 14, 2008Dec 3, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8602991Jun 7, 2010Dec 10, 2013Abbott Diabetes Care Inc.Analyte sensor introducer and methods of useUS8612159Feb 16, 2004Dec 17, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8612163Aug 30, 2012Dec 17, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8613703May 29, 2008Dec 24, 2013Abbott Diabetes Care Inc.Insertion devices and methodsUS8613892Jun 30, 2009Dec 24, 2013Abbott Diabetes Care Inc.Analyte meter with a moveable head and methods of using the sameUS8615282Feb 22, 2006Dec 24, 2013Dexcom, Inc.Analyte sensorUS8617069Jun 20, 2008Dec 31, 2013Abbott Diabetes Care Inc.Health monitorUS8617071Jun 21, 2007Dec 31, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8622903May 25, 2012Jan 7, 2014Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8622905Dec 11, 2009Jan 7, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8622906Dec 21, 2009Jan 7, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8622988Aug 31, 2008Jan 7, 2014Abbott Diabetes Care Inc.Variable rate closed loop control and methodsUS8635046Jun 22, 2011Jan 21, 2014Abbott Diabetes Care Inc.Method and system for evaluating analyte sensor response characteristicsUS8638220May 23, 2011Jan 28, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systemsUS8641618Jun 26, 2008Feb 4, 2014Abbott Diabetes Care Inc.Method and structure for securing a monitoring device elementUS8641619Dec 21, 2009Feb 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8647269Apr 20, 2009Feb 11, 2014Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8649841Apr 3, 2007Feb 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8652043Jul 20, 2012Feb 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8653977Jun 21, 2013Feb 18, 2014Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8660627Mar 17, 2009Feb 25, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8663109Mar 29, 2010Mar 4, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8665091Jun 30, 2009Mar 4, 2014Abbott Diabetes Care Inc.Method and device for determining elapsed sensor lifeUS8666469Nov 16, 2007Mar 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8668645Jan 3, 2003Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8670815Apr 30, 2007Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8672844Feb 27, 2004Mar 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8676287Dec 11, 2009Mar 18, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8676288Jun 22, 2011Mar 18, 2014Dexcom, Inc.Device and method for determining analyte levelsUS8676513Jun 21, 2013Mar 18, 2014Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8676601Apr 8, 2013Mar 18, 2014Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8682408Mar 5, 2010Mar 25, 2014Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8682598Aug 27, 2009Mar 25, 2014Abbott LaboratoriesMethod and system for transferring analyte test dataUS8682615Aug 4, 2012Mar 25, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8684930Jun 29, 2009Apr 1, 2014Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8688188Jun 30, 2009Apr 1, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8690775Apr 11, 2008Apr 8, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8698615Apr 22, 2013Apr 15, 2014Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8700117Dec 8, 2009Apr 15, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8706180Jun 10, 2013Apr 22, 2014Abbott Diabetes Care Inc.Electrochemical analyte sensorUS8710993Nov 21, 2012Apr 29, 2014Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS8718739Dec 28, 2012May 6, 2014Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8718958Mar 12, 2012May 6, 2014Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8718965Jun 24, 2013May 6, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8721545Mar 22, 2010May 13, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8727982Jun 25, 2012May 20, 2014Abbott Diabetes Care Inc.Method and system for providing integrated analyte monitoring and infusion system therapy managementUS8730058Jul 29, 2013May 20, 2014Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8732188Feb 15, 2008May 20, 2014Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determinationUS8734344May 29, 2011May 27, 2014Abbott Diabetes Care Inc.On-body medical device securementUS8734346Apr 30, 2007May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734348Mar 17, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734422Aug 31, 2008May 27, 2014Abbott Diabetes Care Inc.Closed loop control with improved alarm functionsUS8737259Aug 5, 2013May 27, 2014Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8738109Mar 3, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8741590Apr 3, 2007Jun 3, 2014Abbott Diabetes Care Inc.Subcutaneous glucose electrodeUS8744545Mar 3, 2009Jun 3, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8744546Apr 28, 2006Jun 3, 2014Dexcom, Inc.Cellulosic-based resistance domain for an analyte sensorUS8744547Jul 9, 2012Jun 3, 2014Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8750955Nov 2, 2009Jun 10, 2014Dexcom, Inc.Analyte sensorUS8764657Mar 30, 2012Jul 1, 2014Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS8765059Oct 27, 2010Jul 1, 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS8771183Feb 16, 2005Jul 8, 2014Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8774887Mar 24, 2007Jul 8, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8788006Dec 11, 2009Jul 22, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8792953Mar 19, 2010Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8792956Apr 2, 2012Jul 29, 2014Abbott Diabetes Care Inc.Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agentUS8795252Oct 16, 2009Aug 5, 2014Abbott Diabetes Care Inc.Robust closed loop control and methodsUS8798934Jul 23, 2010Aug 5, 2014Abbott Diabetes Care Inc.Real time management of data relating to physiological control of glucose levelsUS8801611Mar 22, 2010Aug 12, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8802006Aug 27, 2012Aug 12, 2014Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8812072Apr 17, 2008Aug 19, 2014Dexcom, Inc.Transcutaneous medical device with variable stiffnessUS8816862Aug 19, 2013Aug 26, 2014Abbott Diabetes Care Inc.Displays for a medical deviceUS8828201Jul 1, 2010Sep 9, 2014Dexcom, Inc.Analyte sensors and methods of manufacturing sameUS8834366Jul 31, 2007Sep 16, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibrationUS8840553Feb 26, 2009Sep 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8852101Sep 30, 2009Oct 7, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS8862198Dec 17, 2012Oct 14, 2014Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8865249Sep 28, 2012Oct 21, 2014Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8876755Jul 14, 2009Nov 4, 2014Abbott Diabetes Care Inc.Closed loop control system interface and methodsUS8880137Apr 18, 2003Nov 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8880138Sep 30, 2005Nov 4, 2014Abbott Diabetes Care Inc.Device for channeling fluid and methods of useUS8886272Feb 22, 2006Nov 11, 2014Dexcom, Inc.Analyte sensorUS8906307Aug 18, 2010Dec 9, 2014Abbott Diabetes Care Inc.Apparatus for providing power management in data communication systemsUS8909314Jul 20, 2011Dec 9, 2014Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8911369Dec 15, 2008Dec 16, 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8915850Mar 28, 2014Dec 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8920319Dec 28, 2012Dec 30, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8924159Jun 1, 2009Dec 30, 2014Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8929968Jul 19, 2010Jan 6, 2015Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8930203Feb 3, 2010Jan 6, 2015Abbott Diabetes Care Inc.Multi-function analyte test device and methods thereforUS8932216Aug 7, 2006Jan 13, 2015Abbott Diabetes Care Inc.Method and system for providing data management in integrated analyte monitoring and infusion systemUS8933664Nov 25, 2013Jan 13, 2015Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8937540Feb 24, 2014Jan 20, 2015Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8954128Oct 18, 2013Feb 10, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8974386Nov 1, 2005Mar 10, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8986208Sep 30, 2008Mar 24, 2015Abbott Diabetes Care Inc.Analyte sensor sensitivity attenuation mitigationUS8986209Jul 13, 2012Mar 24, 2015Dexcom, Inc.Transcutaneous analyte sensorUS8993331Aug 31, 2010Mar 31, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noiseUS9000929Nov 22, 2013Apr 7, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9008743Apr 14, 2008Apr 14, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9011331Dec 29, 2004Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9011332Oct 30, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9014773Mar 7, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9020572Sep 10, 2010Apr 28, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor dataUS9031630Nov 1, 2010May 12, 2015Abbott Diabetes Care Inc.Analyte sensors and methods of useUS9035767May 30, 2013May 19, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9039975Dec 2, 2013May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS9042953Mar 2, 2007May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9044199Mar 10, 2005Jun 2, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9050041May 21, 2012Jun 9, 2015Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS9055901Sep 14, 2012Jun 16, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9060719Dec 13, 2013Jun 23, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9064107Sep 30, 2013Jun 23, 2015Abbott Diabetes Care Inc.Infusion devices and methodsUS9066694Apr 3, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066695Apr 12, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066697Oct 27, 2011Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066709Mar 17, 2014Jun 30, 2015Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS9069536Oct 30, 2012Jun 30, 2015Abbott Diabetes Care Inc.Electronic devices having integrated reset systems and methods thereofUS9072477Jun 21, 2007Jul 7, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9078607Jun 17, 2013Jul 14, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9078626Mar 31, 2011Jul 14, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9088452Jan 31, 2013Jul 21, 2015Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS9095290Feb 27, 2012Aug 4, 2015Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS9109926Dec 8, 2014Aug 18, 2015Abbott Diabetes Care Inc.Method and apparatus for providing power management in data communication systemsUS9113828Jul 9, 2012Aug 25, 2015Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS9119582Jun 30, 2006Sep 1, 2015Abbott Diabetes Care, Inc.Integrated analyte sensor and infusion device and methods thereforUS9125548May 14, 2008Sep 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9131885Jul 1, 2010Sep 15, 2015Dexcom, Inc.Analyte sensors and methods of manufacturing sameUS9135402Oct 24, 2008Sep 15, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9143569Feb 20, 2009Sep 22, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor dataUS9149233Jun 13, 2012Oct 6, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9149234Jun 13, 2012Oct 6, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9155496Feb 18, 2011Oct 13, 2015Dexcom, Inc.Low oxygen in vivo analyte sensorUS9173606Jan 30, 2014Nov 3, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS9173607Jan 30, 2014Nov 3, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS9177456Jun 10, 2013Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9178752Apr 25, 2014Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS9179869Sep 10, 2014Nov 10, 2015Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS9184875Apr 25, 2014Nov 10, 2015Abbott Diabetes Care, Inc.Close proximity communication device and methodsUS9186098Mar 24, 2011Nov 17, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9186113Aug 11, 2014Nov 17, 2015Abbott Diabetes Care Inc.Displays for a medical deviceUS9204827Apr 14, 2008Dec 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9215992Mar 24, 2011Dec 22, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9226701Apr 28, 2010Jan 5, 2016Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor systemUS9226714Jan 8, 2015Jan 5, 2016Abbott Diabetes Care Inc.Displays for a medical deviceUS9237864Jul 1, 2010Jan 19, 2016Dexcom, Inc.Analyte sensors and methods of manufacturing sameUS9247900Jun 4, 2013Feb 2, 2016Dexcom, Inc.Analyte sensorUS9259175Oct 23, 2006Feb 16, 2016Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytesUS9265453Mar 24, 2011Feb 23, 2016Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9289179Apr 11, 2014Mar 22, 2016Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS9310230Jun 24, 2013Apr 12, 2016Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS9314195Aug 31, 2010Apr 19, 2016Abbott Diabetes Care Inc.Analyte signal processing device and methodsUS9314198Apr 3, 2015Apr 19, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9317656Nov 21, 2012Apr 19, 2016Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereofUS9320461Sep 29, 2010Apr 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systemsUS9320462May 5, 2014Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor calibration managementUS9320468Jun 21, 2013Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS9323898Nov 15, 2013Apr 26, 2016Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS9326707Nov 10, 2009May 3, 2016Abbott Diabetes Care Inc.Alarm characterization for analyte monitoring devices and systemsUS9326709Mar 9, 2011May 3, 2016Abbott Diabetes Care Inc.Systems, devices and methods for managing glucose levelsUS9326714Jun 29, 2010May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326716Dec 5, 2014May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326727May 15, 2014May 3, 2016Abbott Diabetes Care Inc.On-body medical device securementUS9328371Jul 16, 2013May 3, 2016Dexcom, Inc.Sensor head for use with implantable devicesUS9332933Sep 29, 2014May 10, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS9332934Feb 8, 2013May 10, 2016Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS9332944Jan 31, 2014May 10, 2016Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS9339217Nov 21, 2012May 17, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods of useUS9339222May 31, 2013May 17, 2016Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensorsUS9339223Dec 30, 2013May 17, 2016Dexcom, Inc.Device and method for determining analyte levelsUS9339238May 16, 2012May 17, 2016Dexcom, Inc.Systems and methods for processing sensor dataUS9351669Sep 30, 2010May 31, 2016Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring deviceUS9351677Mar 4, 2013May 31, 2016Dexcom, Inc.Analyte sensor with increased reference capacityUS9357959Aug 19, 2013Jun 7, 2016Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS9364149Oct 3, 2011Jun 14, 2016Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS9380971Dec 5, 2014Jul 5, 2016Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS20050239154 *Oct 27, 2004Oct 27, 2005Feldman Benjamin JA method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS20060189856 *Apr 25, 2006Aug 24, 2006James PetisceOxygen enhancing membrane systems for implantable devicesUS20090048501 *Jul 14, 2004Feb 19, 2009Therasense, Inc.Glucose measuring device integrated into a holster for a personal area network deviceUS20090105658 *Dec 28, 2005Apr 23, 2009Abbott Diabetes Care, Inc.Infusion sets for the delivery of a therapeutic substance to a patientUS20100185071 *Mar 29, 2010Jul 22, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS20100286496 *Nov 11, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUSRE43399Jun 13, 2008May 22, 2012Dexcom, Inc.Electrode systems for electrochemical sensorsUSRE44695May 1, 2012Jan 7, 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensorEP2407093A1Feb 22, 2006Jan 18, 2012DexCom, Inc.Analyte sensorEP2407094A1Feb 22, 2006Jan 18, 2012DexCom, Inc.Analyte sensorEP2407095A1Feb 22, 2006Jan 18, 2012DexCom, Inc.Analyte sensorEP2499969A1Jun 20, 2006Sep 19, 2012DexCom, Inc.Analyte sensorEP2517623A1Jun 20, 2006Oct 31, 2012DexCom, Inc.Analyte sensorEP2532302A1Jun 20, 2006Dec 12, 2012DexCom, Inc.Analyte sensorEP2561807A1Mar 10, 2006Feb 27, 2013DexCom, Inc.System and methods for processing analyte sensor data for sensor calibrationEP2596747A1Mar 10, 2006May 29, 2013DexCom, Inc.System and methods for processing analyte sensor data for sensor calibrationEP2796090A1Sep 21, 2007Oct 29, 2014DexCom, Inc.Analyte sensorEP2796093A1Mar 25, 2008Oct 29, 2014DexCom, Inc.Analyte sensorEP2829224A2Feb 22, 2006Jan 28, 2015DexCom, Inc.Analyte sensorWO2007120442A2 *Mar 27, 2007Oct 25, 2007Dexcom, Inc.Dual electrode system for a continuous analyte sensorWO2008042918A2Oct 2, 2007Apr 10, 2008Dexcom, Inc.Dual electrode system for a continuous analyte sensorWO2011003035A2Jul 1, 2010Jan 6, 2011Dexcom, Inc.Analyte sensorWO2014004460A1Jun 25, 2013Jan 3, 2014Dexcom, Inc.Use of sensor redundancy to detect sensor failuresWO2014052080A1Sep 16, 2013Apr 3, 2014Dexcom, Inc.Zwitterion surface modifications for continuous sensorsWO2014158405A2Feb 12, 2014Oct 2, 2014Dexcom, Inc.Systems and methods for processing and transmitting sensor dataWO2015156966A1Mar 16, 2015Oct 15, 2015Dexcom, Inc.Sensors for continuous analyte monitoring, and related methods* Cited by examinerClassifications U.S. Classification435/287.2, 600/315International ClassificationG01N, A61B5/00, C12M1/34, C12Q1/00Cooperative ClassificationA61B5/14532, A61B5/14865, C12Q1/002European ClassificationA61B5/1486B, A61B5/145G, C12Q1/00B2Legal EventsDateCodeEventDescriptionApr 14, 2005ASAssignmentOwner name: DEXCOM, INC., CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BURD, JOHN;TAPSAK, MARK;RHODES, RATHBUN;REEL/FRAME:016077/0470Effective date: 20050318RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services